Kisner Daniel L - 28 May 2021 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
Director
Signature
Daniel L. Kisner, M.D., by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
DVAX
Transactions as of
28 May 2021
Transactions value $
$0
Form type
4
Date filed
02 Jun 2021, 19:06
Previous filing
27 May 2021
Next filing
05 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Option (Right to Buy) Award +25K 25K 28 May 2021 Common Stock 25K $8.20 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests fully on May 28, 2022, on the one year anniversary of the grant date.
F2 Not applicable.